Chemomab Therapeutics, a clinical-stage biotech focused on fibro-inflammatory diseases, announced its second-quarter 2025 financial results, highlighting progress in its...

Cocrystal Pharma, a clinical-stage biotech company, has reported favorable safety and tolerability data from its Phase 1 study of...

Vyne Therapeutics, a clinical-stage biopharmaceutical company focused on inflammatory and immune-mediated conditions, reported second-quarter financials alongside a strategic pipeline...

Avicanna’s Q2 2025 results reveal a company navigating a complex cannabis market, demonstrating both progress and persistent challenges. While...

Evaxion A/S, a clinical-stage AI-driven vaccine developer, announced its second-quarter 2025 financial results, highlighting key pipeline advancements and strategic...

Lexeo Therapeutics’ recent business updates reveal a company aggressively pursuing growth and solidifying its position in the genetic medicine...

Cassava Sciences is pivoting to Tuberous Sclerosis Complex (TSC)-related epilepsy, announcing positive preclinical data for its simufilam therapy and...

Abeona Therapeutics has launched Zevaskyn, the first and only gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) wounds, marking...

Medipharm Labs Corp., a pharmaceutical company specializing in precision-based cannabinoids, reported a 14% year-over-year revenue increase to $11.8 million...

MediWound’s Q2 2025 results showcase a company navigating the complex landscape of advanced wound care therapeutics, balancing ongoing commercialization...